Ohio State part of major clinical trial on leukemia

When Judy Moyer was diagnosed in 2015 with the most lethal form of blood cancer, she underwent a treatment plan that has barely improved in 40 years. Less than 20 percent of patients older than 60 with acute myeloid leukemia — a disease of the blood and bone marrow — survive beyond five years. Yet the traditional regimen of toxic chemotherapies developed to combat it in 1973 has remained largely unchanged.